Agios Pharmaceuticals (AGIO) Current Assets (2016 - 2025)
Historic Current Assets for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $942.1 million.
- Agios Pharmaceuticals' Current Assets fell 243.87% to $942.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $942.1 million, marking a year-over-year decrease of 243.87%. This contributed to the annual value of $942.1 million for FY2025, which is 243.87% down from last year.
- Per Agios Pharmaceuticals' latest filing, its Current Assets stood at $942.1 million for Q4 2025, which was down 243.87% from $1.0 billion recorded in Q3 2025.
- In the past 5 years, Agios Pharmaceuticals' Current Assets ranged from a high of $2.4 billion in Q1 2021 and a low of $632.1 million during Q2 2024
- Moreover, its 5-year median value for Current Assets was $953.8 million (2024), whereas its average is $1.0 billion.
- As far as peak fluctuations go, Agios Pharmaceuticals' Current Assets soared by 30102.47% in 2021, and later tumbled by 5859.46% in 2022.
- Over the past 5 years, Agios Pharmaceuticals' Current Assets (Quarter) stood at $1.1 billion in 2021, then decreased by 21.75% to $832.8 million in 2022, then grew by 0.13% to $833.8 million in 2023, then rose by 15.8% to $965.6 million in 2024, then decreased by 2.44% to $942.1 million in 2025.
- Its last three reported values are $942.1 million in Q4 2025, $1.0 billion for Q3 2025, and $1.0 billion during Q2 2025.